Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use ; volume:40 ; number:1 ; day:24 ; month:2 ; year:2024 ; pages:1-8 ; date:1.2024
Drugs & therapy perspectives ; 40, Heft 1 (24.2.2024), 1-8, 1.2024
- Urheber
-
Nie, Tina
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40267-024-01045-0
- URN
-
urn:nbn:de:101:1-2405232102478.518449700242
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nie, Tina
- SpringerLink (Online service)
Ähnliche Objekte (12)
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
Durch Bacillus Calmette-Guerin induzierte Tuberkulose
Correction to: Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use
Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model
Bekämpfung der Tuberkulose: Schutzimpfung mit Bacillus Calmette-Guérin (BCG)
Elicitation of Health State Utilities Associated with Progression from Bacillus Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)
Die intravesikale Immuntherapie mit Bacillus Calmette-Guérin : Fakten, Vergleiche, Ergebnisse
Measles infection causing Bacillus Calmette-Guérin reactivation: a case report
Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency
Untersuchungen zur Adhärenz von Bacillus Calmette Guérin (BCG) an permanenten Blasentumorzellinien
Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
Post-Bacille Calmette–Guerin surveillance for non-muscle invasive bladder cancer: do random biopsies offer an advantage?
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
Durch Bacillus Calmette-Guerin induzierte Tuberkulose
Correction to: Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use
Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model
Bekämpfung der Tuberkulose: Schutzimpfung mit Bacillus Calmette-Guérin (BCG)
Elicitation of Health State Utilities Associated with Progression from Bacillus Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)
Die intravesikale Immuntherapie mit Bacillus Calmette-Guérin : Fakten, Vergleiche, Ergebnisse
Measles infection causing Bacillus Calmette-Guérin reactivation: a case report
Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency
Untersuchungen zur Adhärenz von Bacillus Calmette Guérin (BCG) an permanenten Blasentumorzellinien
Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
Post-Bacille Calmette–Guerin surveillance for non-muscle invasive bladder cancer: do random biopsies offer an advantage?
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
Durch Bacillus Calmette-Guerin induzierte Tuberkulose
Correction to: Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use
Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model
Bekämpfung der Tuberkulose: Schutzimpfung mit Bacillus Calmette-Guérin (BCG)
Elicitation of Health State Utilities Associated with Progression from Bacillus Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)
Die intravesikale Immuntherapie mit Bacillus Calmette-Guérin : Fakten, Vergleiche, Ergebnisse
Measles infection causing Bacillus Calmette-Guérin reactivation: a case report
Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency
Untersuchungen zur Adhärenz von Bacillus Calmette Guérin (BCG) an permanenten Blasentumorzellinien
Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)